Virtual women's and family health clinic for employers, health plans, consumers
Maven Clinic runs a virtual care platform for women's and family health on GCP, React/TypeScript and Node.js, with OpenAI, Gemini and RAG already in the stack. Its adoption of ISO 27001 and ISO 42001, alongside SOC 2 and HITRUST renewal work, points to a deliberate push to formalize AI governance and security for enterprise buyers. Hiring is accelerating and skews senior and staff-level across engineering, product and security.
Notable leadership hires: Sales Director, Head of Member Growth
Maven Clinic is a privately held virtual clinic focused on women's and family health, founded in 2014 and headquartered in New York. It sells to employers and health plans through an enterprise offering covering fertility and family building, maternity and newborn care, parenting and pediatrics, and menopause and midlife. A consumer channel offers direct access to virtual care across many specialties, plus hormone and GLP-1 programs. The company has 201–500 employees, and its current hiring is in the United States.
Maven Clinic builds on GCP with React, TypeScript, JavaScript and Node.js, uses Terraform and GitLab CI/CD, secures access with Okta and Auth0, and runs Salesforce, HubSpot, Braze and Zendesk for go-to-market and support.
Yes. Its stack includes OpenAI, Gemini and RAG, and it is pursuing ISO 42001 certification and AI risk management to govern how it deploys AI.
Yes. Hiring is accelerating, led by engineering and product, with notable demand in security, healthcare, marketing and support, mostly at senior and staff levels in the United States.
Other companies in the same industry, closest in size
Maven Clinic's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.